Equillium News

Equillium | 10-Q: Quarterly report

May 9 17:07 ET

Equillium | 8-K: Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

May 9 16:12 ET

Equillium | DEF 14A: Definitive information statements

Apr 11 16:12 ET

Equillium | DEFA14A: Others

Apr 11 16:12 ET

Equillium | ARS: Annual Report to Security Holders

Apr 11 16:11 ET

Equillium | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 1 17:09 ET

Equillium | 8-K: Current report

Apr 1 08:11 ET

Equillium | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 25 16:30 ET

Equillium | 10-K: Annual report

Mar 25 16:16 ET

Equillium | 8-K: Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Mar 25 16:11 ET

Equillium | 3: Initial statement of beneficial ownership of securities-Officer Tom Penny

Mar 8 17:37 ET

Equillium | 8-K: Current report

Mar 8 16:02 ET

Equillium | 8-K: Current report

Feb 23 17:20 ET

Equillium | 424B5: Prospectus

Feb 23 17:16 ET

Equillium | 8-K: Current report

Feb 22 06:11 ET

Equillium | SC 13G: Statement of acquisition of beneficial ownership by individuals-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)

Jan 19 00:00 ET

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer BRADBURY DANIEL

Jan 3 00:00 ET

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Steel Bruce D.

Jan 3 00:00 ET

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Connelly Stephen

Jan 3 00:00 ET

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Rothman Joel

Jan 3 00:00 ET